Svjetlana Miocinovic

Svjetlana Miocinovic

Auto-generated profile, based on publicly available information

Svjetlana Miocinovic

Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
SMSvjetlana Miocinovic
Svjetlana Miocinovic
SSSuvarchala Somayajula
Suvarchala Somayajula
SCShilpa Chitnis
Shilpa Chitnis
JVJerrold L. Vitek
Jerrold L. Vitek
Review from JAMA Neurology — History, Applications, and Mechanisms of Deep Brain Stimulation

1 May 2004 in NeuroReport
Verified
Journal Article
Closed access
WGWarren M. Grill
Warren M. Grill
ASAndrea N. Snyder
Andrea N. Snyder
SMSvjetlana Miocinovic
Svjetlana Miocinovic
Deep brain stimulation (DBS) is an effective treatment for movement disorders, but the mechanisms are unclear. DBS generates inhibition of neurons surrounding the electrode while simultaneously activating the output axons of local neurons. This dual effect does not explain two hallmarks of DBS effectiveness: symptom relief is dependent on using a sufficiently high-stimulation frequency, and clinical effects are analogous to those produced by lesion. The effect of DBS at different frequencies on the output of intrinsically active neurons was studied using computational models. DBS produced frequency-dependent modulation of the variability of neuronal output, and above a critical frequency stimulation resulted in regular output with zero variance. The resulting loss of information offers an explanation for the two hallmarks of DBS effectiveness.

15 June 2016 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
NSNicole C. Swann
Nicole C. Swann
CHCoralie de Hemptinne
Coralie de Hemptinne
SMSvjetlana Miocinovic
Svjetlana Miocinovic
SQSalman Qasim
Salman Qasim
SWSarah S. Wang
Sarah S. Wang
PSPhilip A. Starr
Philip A. Starr
Hyperkinetic states are common in human movement disorders, but their neural basis remains uncertain. One such condition is dyskinesia, a serious adverse effect of medical and surgical treatment for Parkinson9s disease (PD). To study this, we used a novel, totally implanted, bidirectional neural interface to obtain multisite long-term recordings. We focus our analysis on two patients with PD who experienced frequent dyskinesia and studied them both at rest and during voluntary movement. We show that dyskinesia is associated with a narrowband gamma oscillation in motor cortex between 60 and 90 Hz, a similar, though weaker, oscillation in subthalamic nucleus, and strong phase coherence between the two. Dyskinesia-related oscillations are minimally affected by voluntary movement. When dyskinesia persists during therapeutic deep brain stimulation (DBS), the peak frequency of this signal shifts to half the stimulation frequency. These findings suggest a circuit-level mechanism for the generation of dyskinesia as well as a promising control signal for closed-loop DBS. SIGNIFICANCE STATEMENT Oscillations in brain networks link functionally related brain areas to accomplish thought and action, but this mechanism may be altered or exaggerated by disease states. Invasive recording using implanted electrodes provides a degree of spatial and temporal resolution that is ideal for analysis of network oscillations. Here we used a novel, totally implanted, bidirectional neural interface for chronic multisite brain recordings in humans with Parkinson9s disease. We characterized an oscillation between cortex and subcortical modulators that is associated with a serious adverse effect of therapy for Parkinson9s disease: dyskinesia. The work shows how a perturbation in oscillatory dynamics might lead to a state of excessive movement and also suggests a possible biomarker for feedback-controlled neurostimulation to treat hyperkinetic disorders.

1 September 2006 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
SMSvjetlana Miocinovic
Svjetlana Miocinovic
MPMartin Parent
Martin Parent
CBChristopher R Butson
Christopher R Butson
PHPhilip J. Hahn
Philip J. Hahn
GRGary S. Russo
Gary S. Russo
CMCameron C. McIntyre
Cameron C. McIntyre
The subthalamic nucleus (STN) is the most common target for the treatment of Parkinson’s disease (PD) with deep brain stimulation (DBS). DBS of the globus pallidus internus (GPi) is also effective in the treatment of PD. The output fibers of the GPi that form the lenticular fasciculus pass in close proximity to STN DBS electrodes. In turn, both STN projection neurons and GPi fibers of passage represent possible therapeutic targets of DBS in the STN region. We built a comprehensive computational model of STN DBS in parkinsonian macaques to study the effects of stimulation in a controlled environment. The model consisted of three fundamental components: 1) a three-dimensional (3D) anatomical model of the macaque basal ganglia, 2) a finite element model of the DBS electrode and electric field transmitted to the tissue medium, and 3) multicompartment biophysical models of STN projection neurons, GPi fibers of passage, and internal capsule fibers of passage. Populations of neurons were positioned within the 3D anatomical model. Neurons were stimulated with electrode positions and stimulation parameters defined as clinically effective in two parkinsonian monkeys. The model predicted axonal activation of STN neurons and GPi fibers during STN DBS. Model predictions regarding the degree of GPi fiber activation matched well with experimental recordings in both monkeys. Only axonal activation of the STN neurons showed a statistically significant increase in both monkeys when comparing clinically effective and ineffective stimulation. Nonetheless, both neural targets may play important roles in the therapeutic mechanisms of STN DBS.

1 April 2008 in Neurotherapeutics
Verified
Journal Article
Closed access
MJMatthew D. Johnson
Matthew D. Johnson
SMSvjetlana Miocinovic
Svjetlana Miocinovic
CMCameron C. McIntyre
Cameron C. McIntyre
JVJerrold L. Vitek
Jerrold L. Vitek

3 June 2009 in Journal of Neural Engineering
Verified
Journal Article
Closed access
SLScott F Lempka
Scott F Lempka
SMSvjetlana Miocinovic
Svjetlana Miocinovic
MJMatthew D Johnson
Matthew D Johnson
JVJerrold L Vitek
Jerrold L Vitek
CMCameron C McIntyre
Cameron C McIntyre
Deep brain stimulation (DBS) represents a powerful clinical technology, but a systematic characterization of the electrical interactions between the electrode and the brain is lacking. The goal of this study was to examine the in vivo changes in the DBS electrode impedance that occur after implantation and during clinically relevant stimulation. Clinical DBS devices typically apply high-frequency voltage-controlled stimulation, and as a result, the injected current is directly regulated by the impedance of the electrode-tissue interface. We monitored the impedance of scaled-down clinical DBS electrodes implanted in the thalamus and subthalamic nucleus of a rhesus macaque using electrode impedance spectroscopy (EIS) measurements ranging from 0.5 Hz to 10 kHz. To further characterize our measurements, equivalent circuit models of the electrode-tissue interface were used to quantify the role of various interface components in producing the observed electrode impedance. Following implantation, the DBS electrode impedance increased and a semicircular arc was observed in the high-frequency range of the EIS measurements, commonly referred to as the tissue component of the impedance. Clinically relevant stimulation produced a rapid decrease in electrode impedance with extensive changes in the tissue component. These post-operative and stimulation-induced changes in impedance could play an important role in the observed functional effects of voltage-controlled DBS and should be considered during clinical stimulation parameter selection and chronic animal research studies.